Institutional investors hold a majority ownership of ACT through the 103.50% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2014, these large investors purchased a net $6.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 438.8 Thousand shares of Actavis PLC
NORDEA INVESTMENT MANAGEMENT AB ... Bought 391.9 Thousand shares of Actavis PLC
FIDELITY MANAGEMENT & RESEARCH (... Bought 54.6 Thousand shares of Actavis PLC